Asymmetric reduction enzymatic

Dynamic kinetic resolution of racemic ketones proceeds through asymmetric reduction when the substrate does racemize and the product does not under the applied experimental conditions. Dynamic kinetic resolution of a-alkyl P-keto ester has been performed through enzymatic reduction. One isomer, out of the four possible products for the unselective reduction (Figure 8.38), can be selectively synthesized using biocatalyst, and by changing the biocatalyst or conditions, all of the isomers can be selectively synthesized [29]. 

Zhu, D., Ankati, H., Mukheijee, C. et al. (2007) Asymmetric reduction of /3-ketonitriles with a recombinant carbonyl reductase and enzymatic transformation to optically pure /3-hydroxy carboxylic acids. Organic Letters, 9 (13), 2561-2563. 

Kragl and Wandrey made a comparison for the asymmetric reduction of acetophenone between oxazaborolidine and alcohol dehydrogenase.[59] The oxazaborolidine catalyst was bound to a soluble polystyrene [58] and used borane as the hydrogen donor. The carbonyl reductase was combined with formate dehydrogenase to recycle the cofactor NADH which acts as the hydrogen donor. Both systems were run for a number of residence times in a continuously operated membrane reactor and were directly comparable. With the chemical system, a space-time yield of 1400 g L"1 d"1 and an ee of 94% were reached whereas for the enzymatic system the space-time yield was 88 g L 1 d"1 with an ee of >99%. The catalyst half-life times were... 

Most asymmetric reductions that can be enzymatically effected have been the reactions of ketones. These reactions can be conducted with whole cells as well as with isolated enzymes. In the latter case, of course, at least one equivalent of a cofactor such as NADH or NADPH (nicotinamide adenine dinucleotide) is required to serve as the actual reductant in the reaction system. 

Asymmetric reduction of ketones or aldehydes to chiral alcohols has received considerable attention. Methods to accomplish this include catalytic asymmetric hydrogenation, hydrosilylation, enzymatic reduction, reductions with biomimetic model systems, and chirally modified metal hydride and alkyl metal reagents. This chapter will be concerned with chiral aluminum-containing reducing re-... 

Another example showing the utility of 1 is the asymmetric hydrogenation of vinyl esters which usually are used as acyl donors in enzymatic resolution. In this transformation, vinyl esters are converted to ketones which then undergo asymmetric reductive acylation to give chiral esters as described in Scheme 1.13. The overall reaction thus corresponds to the asymmetric hydrogenation of vinyl ester to the corresponding alkyl esters. 

An example of a whole-cell process is the two-step synthesis of an enantiopure epoxide by asymmetric reduction of an a-chloro ketone (Scheme 6.4), catalyzed by recombinant whole cells of an Escherichia coli sp. overexpressing an (R)-KRED from Lactobacillus kefir and GDH from Thermoplasma acidophilum, to the corresponding chlorohydrin, followed by non-enzymatic base-catalyzed ring closure to the epoxide [17]. 

Wada M, Yoshizumi A et al (2003) Production of a doubly chiral compound, (4R,6R)-4-hydroxy-2,2,6-trimethylcoclohexanone, by two-step enzymatic asymmetric reduction. Appl Environ Microbiol 69 933-937... 

Asymmetric reduction of the ketone on a 1.0-g (4.0-mmol) scale to provide (R)-(-)-2,2-diphenylcyclopentanol (96% ee) has been reported employing (+)-( -chlorodiisopinocampheylborane however, the reaction is extremely slow and inefficient [70% yield, 5 days, 2.6 equiv of (+)-p-chlorodiisopinocampheylborane].5 Other efforts to obtain enantiomerically pure 1 by means of enzymatic hydrolysis of the corresponding racemic acetates using horse liver acetone powder (HLAP) and pig... 

No 3-carboxy-substituted TBCs, derived from L-tryptophan by the Pic-tet-Spengler route, have yet been isolated from mammalian tissues. The same is also true for the dicarboxylic acid 23a derived from the condensation of L-tryptophan with pyruvic acid (36). The 1-carboxy-substituted TBCs 37 and 38, on the other hand, occur in mammalian systems (70,71) and are metabolically decarboxylated (65,S5). Whether a direct enzymatic decarboxylation of racemic material, occurring with the (S) and (R) enantiomers at a different rate, could account for the formation of unequal amounts of the enantiomers of TBC has not been investigated so far. The pyruvic acid route to optically active TBC (Fig. 12) leading from TBC 38a to TBC 29a via DBC 34 is at tifie moment the preferred pathway (85,86,89), although the enzymes involved in the asymmetric reduction leading to TBC 29a and the hydroxylated metabolites TBCs 30a and 33a have been neither isolated nor characterized. 

Do optically active 1-methyl-TIQs, as sketched in Fig. 32 for the synthesis of (7 )-salsolinol, originate from a Pictet-Spengler reaction of dopamine with acetaldehyde derive from ethanol, or are they the result of a Pictet-Spengler reaction of biogenic amines with pyruvic acid, as sketched in Fig. 33 Based on the accumulated data it seems reasonable to propose that optically active TIQs are formed by the pyruvic acid pathway, and that the pyruvic acids may be derived from an impaired glucose metabolism or an impaired amino acid metabolism. Whether the intermediate TIQ-1-carboxylic acids 91a,b are enzymatically decarboxylated to afford 64a,b in a different enantiomeric ratio, or whether optically active TIQs are formed by oxidative decarboxylation of TIQ 91 to DIQ 120, followed by an asymmetric reduction, remains open to question. 

Matsuda T, Watanabe K, Harada T, and Nakamura K. Enzymatic reactions in supercritical CO2 Carboxylation, asymmetric reduction and esterification. Catal. Today 2004 96(3) 103-111. 

Not all organic chemists can be Involved in such exciting projects as the launching of a new anti-AIDS drug. But the chemistry used in this project was invented by chemists in other institutions who had no idea that it would eventually be used to make Crixlvan. The Sharpless asymmetric epoxlda-tion, the catalytic asymmetric reduction, the stereoselective enolate alkylation, and the various methods tried out for the enantiomerically pure amino indanol (resolution, enzymatic kinetic resolution) were developed by organic chemists in research laboratories. Some of these famous chemists like Sharpless invented new methods, some made new compounds, some studied new types of molecules, but all built on the work of other chemists. 

CCCs may obtain chiral compounds by classical resolution, kinetic resolution using chemical or enzymatic metlrods, biocatalysis (enzyme systems, whole cells, or cell isolates), fermentation (from growing whole microorganisms), and stereoselective chemistry (e.g., asymmetric reduction, low-temperature reactions, use of chiral auxiliaries). CCCs may also be CCEs by capitalizing on a key raw material position and going downstream. Along with companies manufacturing chiral molecules primarily for other purposes, such as amino acid producers, these will be the key sources for the asymmetric center. 

Baker s yeast offers the synthetic chemist an enzymatic method for the asymmetric reduction of p-keto esters, a-hydroxyaldehydes and ketones, and p-diketones. Reviews (a) Rene Csuk, R. Glaenzer, B. 1. Chem. Rev. 1991, 91, 49-97. (b) Servi, S. Synthesis, 1990, 1-25. 

Two approaches were studied to obtain (R)-l,3-BDO. The first was based on an enzyme-catalyzed asymmetric reduction of 4-hydroxy-2-butanone, and the second was based on enantioselective oxidation of the undesirable (S)-l,3-BDO in the racemate. As a result of screening for yeasts, fungi, and bacteria, the enzymatic resolution of racemic 1,3-BDO by Candida parapsilosis IFO 1396, which showed differential rates of oxidation for two enantiomers, was found to be the most practical process to produce (R)-l,3-BDO with high enantiomeric excess and yield. 

Fortunately, a host of methods is available for achieving this goal. They include resolution of a D,L-mixture [238] inversion of L-lactic acid derivatives (see Sections 1.2.1.2 and 1.2.2.2) asymmetric reduction of pyruvates catalytically [239], enzymatically [240], or with chiral boranes [241] and diazotization of D-alanine derivatives, which proceeds with net retention of configuration [242,243]. In addition, D-lactic acid can be obtained by the fermentation of glucose with Lactobacillus leichmannii in the presence of calcium carbonate [244],... 

The one-step transformation of 2- or 3-(l-hydroxyalkyl)-2,3-dihydrobenzofurans to 2- or 3-acylbenzofurans with A -bromosuccinimide was performed with good yields <97H(45)1657>. The asymmetric reduction of dihydrobenzofuran ketoxime ethers to enantiomerically enriched chiral hydroxylamines with reagents prepared from borane and norephedrine has been investigated <97TA497>. An enzymatic resolution of a 3-hydroxymethylbenzofuran using Candida rugosa lipase provides an enantioselective synthesis of vitamin E related antioxidants <97TA45>. 

Belleau and Burba (1960) have used Streitwieser s asymmetric reduction method to establish the stereochemistry of the en-Z3rmatic decarboxylation of amino acids. Reduction of p-methoxy-phenylacetaldehyde with 1-deuteroisobornyloxy magnesium bromide yielded p-methoxyphenethyl-l-d alcohol. The alcohol was converted to i -l-ci-tyramine via the tosylate and azide. The fact that enzymatic decarboxylation of S-tyrosine in D2O also yields 12-l-(i-tyramine shows that this reaction proceeds with retention of configuration (Fig. 10). 

As the essential features of enzymatic mechanisms are unraveled, there should be simultaneous utilization of this information in nonenzymatic chemistry. Modern synthetic methods enable subtle, but powerful, electronic and steric forces, such as must exist at the active site in enzymatic reactions, to be brought to bear on functional groups in simple models. The chemist interested in asymmetric reductions and other asymmetric syntheses now faces this interesting challenge. 

The approach using cyclodextrin as a binding site has also been developed. Cyclodextrins are widely utilized in biomimetic chemistry as simple models for an enzyme because they have the ability to form inclusion complexes with a variety of molecules and because they have catalytic activity toward some reactions. Kojima et al. (1980, 1981) reported the acceleration in the reduction of ninhydrin and some dyes by a 1,4-dihydronicotinamide attached to 3 Cyclodextrin. Saturation kinetics similar to enzymatic reactions were observed here, which indicates that the reduction proceeds through a complex. Since the cavity of the cyclodextrin molecule has a chiral environment due to the asymmetry of D-glucose units, these chiralities are expected to be effective for the induction of asymmetry into the substrate. Asymmetric reduction with NAD(P)H models of this type, however, has not been reported. Asymmetric reduction by a 1,4-dihydronicotinamide derivative took place in an aqueous solution of cyclodextrin (Baba et al. 1978), although the optical yield from the reduction was quite low. Trifluoromethyl aryl ketones were reduced by PNAH in 1.1 to 5.8 % e.e. in the presence of 3-cyclodextrin. Sodium borohydride works as well (Table 18). In addition to cyclodextrin, Baba et al. also found that the asymmetric reductions can be accomplished in the presence of bovine serum albumin (BSA) which is a carrier protein in plasma. 

---